184 related articles for article (PubMed ID: 19073519)
41. Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer.
Shah A; Swain WA; Richardson D; Edwards J; Stewart DJ; Richardson CM; Swinson DE; Patel D; Jones JL; O'Byrne KJ
Clin Cancer Res; 2005 Apr; 11(8):2930-6. PubMed ID: 15837744
[TBL] [Abstract][Full Text] [Related]
42. Prognostic significance of synaptophysin in stage I of squamous carcinoma and adenocarcinoma of the lung.
González-Aragoneses F; Moreno-Mata N; Cebollero-Presmanes M; García-Yuste M; Cañizares-Carretero MA; Molins-López-Rodó L; Quevedo-Losada S; Torres-Lanzas J; Alvarez-Fernández E;
Cancer; 2007 Oct; 110(8):1776-81. PubMed ID: 17724707
[TBL] [Abstract][Full Text] [Related]
43. The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung.
Anton RC; Coffey DM; Gondo MM; Stephenson MA; Brown RW; Cagle PT
Mod Pathol; 2000 Nov; 13(11):1167-72. PubMed ID: 11106072
[TBL] [Abstract][Full Text] [Related]
44. Prognostic role of protease-activated receptors 1 and 4 in resected stage IB non-small-cell lung cancer.
Ghio P; Cappia S; Selvaggi G; Novello S; Lausi P; Zecchina G; Papotti M; Borasio P; Scagliotti GV
Clin Lung Cancer; 2006 May; 7(6):395-400. PubMed ID: 16800965
[TBL] [Abstract][Full Text] [Related]
45. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma.
Imoto H; Osaki T; Taga S; Ohgami A; Ichiyoshi Y; Yasumoto K
J Thorac Cardiovasc Surg; 1998 May; 115(5):1007-14. PubMed ID: 9605068
[TBL] [Abstract][Full Text] [Related]
46. Analysis of the prognostic impact of nestin expression in non-small cell lung cancer.
Skarda J; Kolar Z; Janikova M; Radova L; Kolek V; Fridman E; Kopolovic J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):135-42. PubMed ID: 22837134
[TBL] [Abstract][Full Text] [Related]
47. Cytoplasmic and nuclear maspin expression in lung carcinomas: an immunohistochemical study using tissue microarrays.
Zheng HC; Saito H; Masuda S; Wang ZG; Takano Y
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):459-65. PubMed ID: 18665036
[TBL] [Abstract][Full Text] [Related]
48. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
[TBL] [Abstract][Full Text] [Related]
49. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
[TBL] [Abstract][Full Text] [Related]
50. HSP90B1 overexpression predicts poor prognosis in NSCLC patients.
Xu Y; Chen Z; Zhang G; Xi Y; Sun R; Wang X; Wang W; Chai F; Li X
Tumour Biol; 2016 Oct; 37(10):14321-14328. PubMed ID: 27599983
[TBL] [Abstract][Full Text] [Related]
51. Expression of p63, TTF-1 and Maspin in Non-Small Cell Lung Carcinoma and Their Effect on the Prognosis and Differential Diagnosis.
Yaman B; Nart D; Ekren PK; Çok G; Veral A
Turk Patoloji Derg; 2015; 31(3):163-74. PubMed ID: 26456962
[TBL] [Abstract][Full Text] [Related]
52. Cytoplasmic expression of maspin predicts unfavourable prognosis in patients with squamous cell carcinoma of the lung.
Matsuoka Y; Takagi Y; Nosaka K; Sakabe T; Haruki T; Araki K; Taniguchi Y; Shiomi T; Nakamura H; Umekita Y
Histopathology; 2016 Jul; 69(1):114-20. PubMed ID: 27297724
[TBL] [Abstract][Full Text] [Related]
53. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
[TBL] [Abstract][Full Text] [Related]
54. Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.
Bircan A; Bircan S; Kapucuoglu N; Songur N; Ozturk O; Akkaya A
Pathol Oncol Res; 2010 Dec; 16(4):553-61. PubMed ID: 20349288
[TBL] [Abstract][Full Text] [Related]
55. Increased expression of integrin-linked kinase is associated with shorter survival in non-small cell lung cancer.
Takanami I
BMC Cancer; 2005 Jan; 5():1. PubMed ID: 15631637
[TBL] [Abstract][Full Text] [Related]
56. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411
[TBL] [Abstract][Full Text] [Related]
57. Different biomarkers in non-small cell lung cancer in blood vessel invasion.
Zhang C; Liu Y; Guo S; Zhang J
Cell Biochem Biophys; 2014 Nov; 70(2):777-84. PubMed ID: 24801771
[TBL] [Abstract][Full Text] [Related]
58. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
59. Clinical significance of p21 expression in non-small-cell lung cancer.
Shoji T; Tanaka F; Takata T; Yanagihara K; Otake Y; Hanaoka N; Miyahara R; Nakagawa T; Kawano Y; Ishikawa S; Katakura H; Wada H
J Clin Oncol; 2002 Sep; 20(18):3865-71. PubMed ID: 12228206
[TBL] [Abstract][Full Text] [Related]
60. Cytoplasmic maspin expression is a predictor of poor prognosis in patients with lung adenocarcinoma measuring <3 cm.
Takagi Y; Matsuoka Y; Shiomi T; Nosaka K; Takeda C; Haruki T; Araki K; Taniguchi Y; Nakamura H; Umekita Y
Histopathology; 2015 Apr; 66(5):732-9. PubMed ID: 25322663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]